University of Gothenburg, Sweden
Clinical and Translational Allergy, one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology is a peer-reviewed, open access journal which provides a platform for the dissemination of allergy research, reviews, brief communications, as well as EAACI position papers, Task Force Reports and guidelines amongst an international scientific audience.
Open access publishing enables free access to all content ensuring a wide dissemination of articles; the electronic format and expert peer review allows for very rapid publication. Clinical and Translational Allergy is an international journal reaching out far beyond the borders of Europe, and invites clinicians and researchers from all countries of the world to contribute.
All fields of research within allergy and asthma are showing explosive development at this time, and it is a pleasure and honour to function as an Editor-in-Chief of a key open-access journal in this exciting field. My own research focus is to study asthma from a clinical and translational angle, to try to understand the mechanisms of phenotypes and endotypes of this complex disease. Indeed, we are just now finding out more and more about the immunology and mechanisms of different allergic diseases, and therefore it is very timely to launch the journal Clinical and Translational Allergy at this time . Furthermore, many novel therapies are being tested in different allergic diseases, and the next decades of research will certainly provide many exciting new studies to the medical community.
Jan Lötvall is currently Professor at the Department of Internal Medicine, and Chairman of the Krefting Research Centre at University of Gothenburg, Sweden. He is also the former President of the European Academy of Allergy and Clinical Immunology (EAACI), the Academic association behind this journal.